1. Home
  2. CVM vs GROW Comparison

CVM vs GROW Comparison

Compare CVM & GROW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CVM
  • GROW
  • Stock Information
  • Founded
  • CVM 1983
  • GROW 1968
  • Country
  • CVM United States
  • GROW United States
  • Employees
  • CVM N/A
  • GROW N/A
  • Industry
  • CVM Biotechnology: Biological Products (No Diagnostic Substances)
  • GROW Investment Managers
  • Sector
  • CVM Health Care
  • GROW Finance
  • Exchange
  • CVM Nasdaq
  • GROW Nasdaq
  • Market Cap
  • CVM 35.7M
  • GROW 33.9M
  • IPO Year
  • CVM 1987
  • GROW N/A
  • Fundamental
  • Price
  • CVM $0.56
  • GROW $2.39
  • Analyst Decision
  • CVM
  • GROW
  • Analyst Count
  • CVM 0
  • GROW 0
  • Target Price
  • CVM N/A
  • GROW N/A
  • AVG Volume (30 Days)
  • CVM 459.4K
  • GROW 79.5K
  • Earning Date
  • CVM 12-19-2024
  • GROW 11-07-2024
  • Dividend Yield
  • CVM N/A
  • GROW 3.76%
  • EPS Growth
  • CVM N/A
  • GROW N/A
  • EPS
  • CVM N/A
  • GROW 0.12
  • Revenue
  • CVM N/A
  • GROW $10,008,000.00
  • Revenue This Year
  • CVM N/A
  • GROW N/A
  • Revenue Next Year
  • CVM $3,412.81
  • GROW N/A
  • P/E Ratio
  • CVM N/A
  • GROW $19.77
  • Revenue Growth
  • CVM N/A
  • GROW N/A
  • 52 Week Low
  • CVM $0.54
  • GROW $2.38
  • 52 Week High
  • CVM $3.23
  • GROW $3.11
  • Technical
  • Relative Strength Index (RSI)
  • CVM 14.93
  • GROW 40.48
  • Support Level
  • CVM $0.54
  • GROW $2.43
  • Resistance Level
  • CVM $0.92
  • GROW $2.53
  • Average True Range (ATR)
  • CVM 0.06
  • GROW 0.06
  • MACD
  • CVM -0.02
  • GROW -0.00
  • Stochastic Oscillator
  • CVM 5.18
  • GROW 0.00

About CVM Cel-Sci Corporation

CEL-SCI Corp is a player in the biotechnology sector. It is engaged in the research and development at developing the treatment of cancer and other diseases by using the immune system. The Company's core capabilities that include are drug discovery, research, development and manufacturing of complex biological substances. It is focused on the development of Multikine (Leukocyte Interleukin, Injection), investigational immunotherapy under development for the treatment of certain head and neck cancers, and anal warts or cervical dysplasia.

About GROW U.S. Global Investors Inc.

US Global Investors Inc is a registered investment advisory firm. The company manages the following business segments: Investment management services; through which the company offers, to U.S. Global Investors Funds (USGIF or the Funds) and exchange-traded fund (ETF) clients, a range of investment management products and services to meet the needs of individual and institutional investors; and Corporate Investments, through which the company invests for its own account in an effort to add growth and value to its cash position. It derives all its revenue from Investment management services.

Share on Social Networks: